CNS Pharmaceuticals sold 17.5M shares via ATM; shares outstanding now 74.96M

CNS Pharmaceuticals, Inc.

Sold 17,475,827 shares under at-the-market agreement since last 10-Q (Sept 30, 2024).
As of Jan 3, 2025, common shares outstanding increased to 74,962,533 from ~57.5M.
No disclosure of pricing or use of proceeds; significant dilution (~30%) for existing holders.

item 7.01 item 8.01 item 9.01

CNS Pharmaceuticals, Inc. filing history →

Source: SEC EDGAR

accession 0001683168-25-000077

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.